A new type of treatment for osteoarthritis, currently in canine clinical trials, shows promise for eventual use in humans.
The treatment, developed by Cornell biomedical engineers, is a synthetic version of a naturally occurring joint lubricant that binds to the surface of cartilage in joints and acts as a cushion during high-impact activities, such as running.
“When the production of that specific lubricant goes down, it creates higher contact between the surfaces of the joint and, over time, it leads to osteoarthritis,” said David Putnam, a professor in the College of Engineering with appointments in the Meinig School of Biomedical Engineering and the Smith School of Chemical and Biomolecular Engineering.
Putnam is senior author of “Boundary Mode Lubrication of Articular Cartilage With a Biomimetic Diblock Copolymer,” published June 4 in Proceedings of the National Academy of Sciences, USA. Zhexun Sun, a postdoctoral researcher in Putnam’s lab, is the paper’s first author.
The study focuses on a naturally occurring joint lubricant called lubricin, the production of which declines following traumatic injuries to a joint, such as a ligament tear in a knee.
The knee is lubricated in two ways – hydrodynamic mode and boundary mode.
Hydrodynamic mode lubrication occurs when the joint is moving fast and there isn’t a strong force pushing down on it. In this mode, joints are lubricated by compounds like hyaluronic acid (HA) that are thick and gooey, like car oil. There are numerous HA products on the market, approved by the Food and Drug Administration, for treating hydrodynamic mode lubrication disorders.
But HA is ineffective when strong forces are pushing down on the joint, such as those that occur during running or jumping. In these instances, thick gooey HA squirts out from between the cartilage surfaces, and boundary mode lubrication is necessary. Under these forces, lubricin binds to the surface of the cartilage. It contains sugars that hold on to water, to cushion hard forces on the knee.
In the paper, the researchers describe a synthetic polymer they developed that mimics the function of lubricin and is much easier to produce. “We are in clinical trials, with dogs that have osteoarthritis, with our collaborators at Cornell’s College of Veterinary Medicine,” Putnam said.
Those collaborators – Ursula Krotscheck and Kei Hayashi, both associate professors in the Section of Small Animal Surgery in the Department of Clinical Sciences – use a force plate to measure the efficacy of the treatments. The force plate quantifies the amount of force that a dog exerts with each paw, to measure whether they are favoring one paw over another.
“Once we finalize the efficacy study in dogs, we will be in a very good position to market the material for veterinary osteoarthritis treatment,” Putnam said. From there, the human market for a lubricin substitute should follow, just as HA has been made available for human use, mainly in knees.
The Latest on: Osteoarthritis
via Google News
The Latest on: Osteoarthritis
- Osteoarthritis Therapeutics Market Size Surpass Around USD 11.5 Billion by 2027on March 5, 2021 at 2:56 pm
The osteoarthritis therapeutics market size is projected to surpass USD 11.5 billion by 2027 and growing at a CAGR of 8.9% from 2020 to 2027. The growth of this market is driven by significant ...
- Can AI fight racial bias in treating knee pain?on March 4, 2021 at 2:19 am
Traditional approaches to pain management don't treat all patients the same. Artificial intelligence may eliminate racial bias and level the playing field.
- Reduced serum levels of anti-Mullerian hormone is a putative biomarker of early knee osteoarthritis in middle-aged females at menopausal transitionon March 2, 2021 at 5:11 am
A recent epidemiological study revealed that the highest prevalence of early knee osteoarthritis (OA) was observed in females aged ≥ 50 years. The major causal factor of early knee OA was sex. Despite ...
- Telephone CBT-I Shown to Improve Sleep, Fatigue in Older Adults With Osteoarthritis Painon February 26, 2021 at 10:54 am
Patients with osteoarthritis-related pain were shown to benefit from cognitive behavioral therapy for insomnia (CBT-I) via telephone, in which the treatment significantly improved sleep and fatigue ...
- Study shows opioid use among US patients with knee osteoarthritis costs 14 billion dollars in societal costson February 24, 2021 at 11:50 pm
Although guidelines do not recommend use of opioids to manage pain for individuals with knee osteoarthritis, a recent study published early online in Arthritis Care & Research, an official journal of ...
- Research shows the effectiveness of a digital healthcare treatment for osteoarthritison February 24, 2021 at 4:12 pm
The steadily increasing prevalence and high costs of treating chronic joint pain worldwide poses a challenge for healthcare systems and healthcare payers.
- Study finds digital treatment for osteoarthritis is superior to traditional routine careon February 24, 2021 at 9:41 am
The steadily increasing prevalence and high costs of treating chronic joint pain worldwide poses a challenge for healthcare systems and healthcare payers. New research published today in JAMA Network ...
- Kessler team receives funding to study factors leading to osteoarthritis after knee injuryon February 22, 2021 at 6:13 pm
Gerard Malanga, MD, and Nathan Hogaboom, PhD, of Kessler Foundation received a $185,707 award from The Geneva Foundation (Geneva) to study factors contributing to the development of osteoarthritis ...
- Kessler Team tests regenerative approach to preventing osteoarthritis after knee injuryon February 22, 2021 at 8:44 am
Osteoarthritis of the knee is one of the most common causes of disability among service members who are medically separated from active duty. ''We anticipate that regenerative interventions will ...
- Zoetis’ Osteoarthritis Therapy For Cats Authorized In Europe; Street Sees 26% Upsideon February 22, 2021 at 4:38 am
Solensia is developed as a therapy to relieve osteoarthritis pain in cats. Osteoarthritis has a high prevalence rate in cats affecting about 40%. It can generate pain and may reduce quality of life if ...
via Bing News